Fundz

Paradigm Biopharmaceuticals Appoints Dr Daniel Furtner as Chief Medical Officer

PRIVATESep 17, 2026
New to company · from CSL“Most recently, he was Senior Director of Medical Affairs for the Asia Pacific region at CSL in Melbourne, following roles of increasing responsibility at Abbott and AbbVie and at Janssen”

Position

Chief Medical Officer

Company

Paradigm Biopharmaceuticals

Daniel Furtner
MelbourneBiotechnologyHealth CareTherapeutics

Description

Paradigm Biopharmaceuticals has appointed Dr Daniel Furtner as its new Chief Medical Officer. He succeeds Dr Donna Skerrett, who will remain with the company as Senior Scientific Advisor.

Quick answer

Paradigm Biopharmaceuticals Appoints Dr Daniel Furtner as Chief Medical Officer (September 17, 2026). Paradigm Biopharmaceuticals is based in Melbourne, Victoria, Australia.

Who is the new Chief Medical Officer at Paradigm Biopharmaceuticals?
Paradigm Biopharmaceuticals named Daniel Furtner Chief Medical Officer, announced September 17, 2026.
What did Paradigm Biopharmaceuticals announce on September 17, 2026?
Paradigm Biopharmaceuticals has appointed Dr Daniel Furtner as its new Chief Medical Officer. He succeeds Dr Donna Skerrett, who will remain with the company as Senior Scientific Advisor.
Where did Daniel Furtner work before joining Paradigm Biopharmaceuticals?
Daniel Furtner joins from CSL.
What does Paradigm Biopharmaceuticals do?
Paradigm Biopharmaceuticals is a Melbourne-based biotechnology company focused on innovative treatments for patients with osteoarthritis.
Where is Paradigm Biopharmaceuticals based?
Paradigm Biopharmaceuticals is based in Melbourne, Victoria, Australia.
Which similar companies made leadership changes around the same time?
Cyllene Therapeutics (September 17, 2026), Oxford Brain Diagnostics (September 15, 2026), AdvanCell (September 15, 2026) and Serapha Bio (September 15, 2026) also announced leadership changes within 45 days of Paradigm Biopharmaceuticals.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Paradigm Biopharmaceuticals, and when

A new leader at Paradigm Biopharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Paradigm Biopharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Paradigm Biopharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Paradigm Biopharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Paradigm Biopharmaceuticals

Location

Melbourne, Victoria, Australia

About

Paradigm Biopharmaceuticals is a Melbourne-based biotechnology company focused on innovative treatments for patients with osteoarthritis. They are currently advancing their Phase 3 clinical trial and preparing for regulatory submissions. The company aims to improve the quality of life for individuals affected by joint diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Paradigm Biopharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Paradigm Biopharmaceuticals's next move

Learn about Strategic plan

Paradigm Biopharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.